title: Treatment of PC12 cells by nerve growth factor, dexamethasone, and forskolin. Effects on cell morphology and expression of neurotensin and tyrosine hydroxylase.
abstract: Several lines of anatomical, neurochemical, electrophysiological, and behavioral evidence suggest the existence of physiological interactions between neurotensin (NT) and the brain dopaminergic systems. Thus, NT has been shown to exert a neuroleptic-like action and could be implicated in the pathogenesis and treatment of schizophrenia. It is thus of particular importance to develop in vitro cell culture systems as models to study such interactions. Rat adrenal pheochromocytoma PC12 cells, which expressed high levels of tyrosine hydroxylase, were used in the present study. In contrast to rat brain cells in primary cultures, PC12 cells did not express functional NT receptors. However, they were able to express both NTmRNA and NT in response to NGF, forskolin, and dexamethasone. Those neurochemical modifications furthermore may be related to changes in the morphology of the PC12 cells in response to NGF, forskolin, and dexamethasone alone or in combination. These data suggest that PC12 cells may provide a useful model to study in vitro the regulation of both catecholamine and neurotensin phenotypes.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Hôpital Saint Antoine, Paris, France.
authors.forename: T
authors.initials: T
authors.lastname: Caillaud
authors.forename: W Y
authors.initials: WY
authors.lastname: Opstal
authors.forename: V
authors.initials: V
authors.lastname: Scarceriaux
authors.forename: C
authors.initials: C
authors.lastname: Billardon
authors.forename: W
authors.initials: W
authors.lastname: Rostene
mesh_terms: D000818:Animals; D002395:Catecholamines / Q000096:biosynthesis; D002454:Cell Differentiation / Q000187:drug effects; D005576:Colforsin / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D009414:Nerve Growth Factors / Q000494:pharmacology*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis* / Q000235:genetics; D016501:Neurites / Q000378:metabolism; D009496:Neurotensin / Q000096:biosynthesis* / Q000235:genetics; D016716:PC12 Cells / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D010641:Phenotype; D051381:Rats; D017208:Rats, Wistar; D018028:Receptors, Neurotensin / Q000032:analysis; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D002395:Catecholamines; D009363:Neoplasm Proteins; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D018028:Receptors, Neurotensin; D005576:Colforsin; D009496:Neurotensin; D003907:Dexamethasone; D014446:Tyrosine 3-Monooxygenase